Ajooni Biotech Ltd
Incorporated in 2010, Ajooni Biotech Ltd is a PURE VEG. animal health care solutions company. It is a significant player in the animal feed and aquaculture sectors.[1]
- Market Cap ₹ 123 Cr.
- Current Price ₹ 7.14
- High / Low ₹ 10.3 / 4.32
- Stock P/E 45.0
- Book Value ₹ 5.07
- Dividend Yield 0.00 %
- ROCE 7.76 %
- ROE 5.12 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Debtor days have improved from 76.0 to 59.1 days.
- Company's median sales growth is 27.0% of last 10 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 26.9%
- Company has a low return on equity of 4.97% over last 3 years.
- Promoter holding has decreased over last 3 years: -25.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Food - Processing - Indian
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-0 | 1 | 7 | 13 | 29 | 42 | 40 | 40 | 51 | 74 | 74 | 80 | 105 | |
-0 | 1 | 7 | 13 | 28 | 41 | 39 | 39 | 49 | 71 | 72 | 78 | 101 | |
Operating Profit | -0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 2 | 4 |
OPM % | 2% | 2% | 2% | 2% | 2% | 2% | 3% | 3% | 4% | 4% | 3% | 4% | |
-0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | |
Interest | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 |
Depreciation | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Profit before tax | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 4 |
Tax % | -0% | 27% | 29% | 28% | 20% | 15% | 29% | 26% | 28% | 28% | 28% | ||
-0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 | |
EPS in Rs | 0.02 | 0.12 | 0.18 | 0.36 | 0.03 | 0.03 | 0.02 | 0.02 | 0.05 | 0.06 | 0.12 | 0.16 | |
Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
Compounded Sales Growth | |
---|---|
10 Years: | 64% |
5 Years: | 15% |
3 Years: | 16% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | 71% |
5 Years: | 39% |
3 Years: | 80% |
TTM: | 53% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 26% |
3 Years: | -20% |
1 Year: | 34% |
Return on Equity | |
---|---|
10 Years: | 5% |
5 Years: | 4% |
3 Years: | 5% |
Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.24 | 0.24 | 0.24 | 0.33 | 6 | 6 | 8 | 10 | 10 | 18 | 18 | 34 |
Reserves | -0 | 0 | 0 | 0 | 1 | 5 | 6 | 7 | 6 | 6 | 24 | 25 | 52 |
-0 | -0 | -0 | 1 | 1 | 5 | 5 | 5 | 7 | 5 | 5 | 2 | 2 | |
-0 | 0 | 1 | 1 | 11 | 4 | 1 | 2 | 6 | 7 | 12 | 3 | 1 | |
Total Liabilities | 0 | 0 | 2 | 2 | 13 | 19 | 18 | 23 | 28 | 29 | 59 | 48 | 89 |
-0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 5 | 6 | 6 | 10 | 10 | |
CWIP | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 1 | 1 |
Investments | -0 | -0 | -0 | -0 | 6 | 6 | 4 | 3 | 1 | 1 | 4 | 2 | 4 |
0 | 0 | 1 | 2 | 6 | 12 | 13 | 18 | 22 | 22 | 48 | 34 | 74 | |
Total Assets | 0 | 0 | 2 | 2 | 13 | 19 | 18 | 23 | 28 | 29 | 59 | 48 | 89 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0 | 0 | -1 | -3 | -3 | -5 | -4 | 1 | 4 | -6 | -4 | ||
-0 | -0 | -0 | -2 | -0 | 1 | 0 | -3 | -2 | -16 | 8 | ||
-0 | 0 | 1 | 5 | 8 | -1 | 3 | 2 | -2 | 22 | -4 | ||
Net Cash Flow | -0 | 0 | -0 | 0 | 5 | -5 | -1 | 0 | -0 | 0 | 0 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 58 | 40 | 33 | 17 | 25 | 44 | 115 | 98 | 68 | 101 | 59 | |
Inventory Days | 141 | 22 | 14 | 63 | 19 | 51 | 34 | 46 | 34 | 39 | 80 | |
Days Payable | 100 | 66 | 27 | 79 | 9 | 12 | 20 | 46 | 39 | 56 | 8 | |
Cash Conversion Cycle | 99 | -4 | 20 | 1 | 35 | 84 | 129 | 98 | 63 | 83 | 131 | |
Working Capital Days | 96 | 5 | 9 | -29 | 35 | 90 | 138 | 112 | 72 | 111 | 134 | |
ROCE % | -0% | 28% | 18% | 37% | 10% | 4% | 4% | 5% | 9% | 6% | 8% |
Documents
Announcements
-
Integrated Filing- Financial
22 February 2025 - Format of Integrated filing (financial) for the quarter ended December 31, 2024
-
Updates
18 February 2025 - Ajooni Biotech Limited has informed regarding 'Update on Intimation submitted on 03.01.2025 regarding Appointment of Director stating Disclosure of non-Debarment statement'.
-
Copy of Newspaper Publication
14 February 2025 - Ajooni Biotech Limited has informed about Copy of Newspaper Publication
-
Statement of deviation(s) or variation(s) under Reg. 32
13 February 2025 - Ajooni Biotech Limited has informed about statement of deviation(s) or variation(s) under Reg. 32
-
Outcome of Board Meeting
13 February 2025 - Ajooni Biotech Limited has informed regarding Board meeting held on February 13, 2025.
Business Overview:[1]
ABL was incorporated in February 2010 and was promoted by Mr Jasjot Singh (chairman and managing director). It manufactures a variety of compound animal feed such as cattle feed, cattle feed chips, camel feed, cotton oil cake, mustard oil cake and a wide range of feed supplements. Facilities in Khanna, Punjab, have a total installed capacity of 60,000 MTPA.